ctDNA testing post-surgery identifies high-risk stage 3 colon cancer patients more accurately than traditional staging methods. Detectable ctDNA correlates with a four- to six-fold increased risk of ...
Medicare beneficiaries who underwent colon or lung cancer surgery at hospitals that subsequently closed had higher risks for postoperative complications, but most patients had alternative surgical ...
Defining cure in stage II and III colon cancer has been challenging, and has never been systematically studied. In an analysis of 15 randomized trials, colon cancer relapse risk fell to 0.5% by year 6 ...
Research published in The Lancet Gastroenterology & Hepatology provides robust evidence for the use of a digital visualisation and decision support ...
Data support routine use of circulating tumor DNA testing in management of stage III colon cancer patients Tumor fraction analysis provides further insights for patient management in patients with ...
Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon cancer have ...
A Scandinavian clinical trial has revealed that low-dose aspirin can halve the risk of colon and rectal cancer recurrence in patients with specific genetic mutations. The research, involving over ...
The drug is sometimes prescribed to certain at-risk people—but what does the science say?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results